Citadel Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Citadel Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49,552	Closed	-$2.91M	–	13558
2025 Q4	$3.08M	Buy	49,552 +12,135	+32%	+$749K	﹤0.01%	5107
2025 Q3	$2.25M	Sell	37,417 -3,881	-9%	-$237K	﹤0.01%	5844
2025 Q2	$2.59M	Sell	41,298 -56,706	-58%	-$3.41M	﹤0.01%	5235
2025 Q1	$5.9M	Sell	98,004 -53,508	-35%	-$3.32M	﹤0.01%	3623
2024 Q4	$8.84M	Buy	151,512 +115,747	+324%	+$6.88M	﹤0.01%	3137
2024 Q3	$2.12M	Sell	35,765 -47,398	-57%	-$2.71M	﹤0.01%	5427
2024 Q2	$4.66M	Sell	83,163 -124,052	-60%	-$6.94M	﹤0.01%	3854
2024 Q1	$12.1M	Buy	207,215 +182,970	+755%	+$10.3M	﹤0.01%	2672
2023 Q4	$1.31M	Sell	24,245 -24,561	-50%	-$1.2M	﹤0.01%	6142
2023 Q3	$2.37M	Buy	48,806 +31,282	+179%	+$1.66M	﹤0.01%	4911
2023 Q2	$989K	Sell	17,524 -39,557	-69%	-$2.18M	﹤0.01%	6471
2023 Q1	$3.08M	Buy	57,081 +34,347	+151%	+$1.83M	﹤0.01%	4587
2022 Q4	$1.2M	Sell	22,734 -5,650	-20%	-$287K	﹤0.01%	6472
2022 Q3	$1.34M	Sell	28,384 -8,098	-22%	-$420K	﹤0.01%	6379
2022 Q2	$1.84M	Sell	36,482 -37,321	-51%	-$2.03M	﹤0.01%	5703
2022 Q1	$4.5M	Buy	73,803 +33,616	+84%	+$2M	﹤0.01%	4385
2021 Q4	$2.65M	Sell	40,187 -11,982	-23%	-$767K	﹤0.01%	5586
2021 Q3	$3.27M	Buy	+52,169	New	+$3.33M	﹤0.01%	5172
2021 Q2	–	Sell	-146,310	Closed	-$8.46M	–	14010
2021 Q1	$8.06M	Buy	+146,310	New	+$8.11M	﹤0.01%	3316
2020 Q3	–	Sell	-154,554	Closed	-$6.82M	–	10366
2020 Q2	$6.82M	Buy	+154,554	New	+$6.6M	﹤0.01%	2663
2020 Q1	–	Sell	-82,338	Closed	-$3.63M	–	9854
2019 Q4	$3.63M	Buy	+82,338	New	+$3.46M	﹤0.01%	3525
2019 Q2	–	Sell	-102,042	Closed	-$3.94M	–	9488
2019 Q1	$3.94M	Buy	+102,042	New	+$3.7M	﹤0.01%	3325
2018 Q4	–	Sell	-61,434	Closed	-$2.33M	–	9415
2018 Q3	$2.33M	Buy	+61,434	New	+$2.18M	﹤0.01%	4154
2018 Q1	–	Sell	-100,914	Closed	-$2.92M	–	8505
2017 Q4	$2.92M	Buy	+100,914	New	+$2.91M	﹤0.01%	3123
2017 Q2	–	Sell	-11,154	Closed	-$281K	–	7737
2017 Q1	$281K	Buy	+11,154	New	+$270K	﹤0.01%	5970
2016 Q3	–	Sell	-192,390	Closed	-$4.35M	–	7445
2016 Q2	$4.35M	Sell	192,390 -47,664	-20%	-$1.03M	﹤0.01%	1940
2016 Q1	$4.9M	Buy	240,054 +155,070	+182%	+$3.01M	0.01%	1801
2015 Q4	$1.74M	Sell	84,984 -97,122	-53%	-$1.94M	﹤0.01%	2887
2015 Q3	$3.38M	Sell	182,106 -67,008	-27%	-$1.35M	﹤0.01%	2333
2015 Q2	$4.97M	Buy	+249,114	New	+$4.99M	﹤0.01%	2078
2015 Q1	–	Sell	-84,216	Closed	-$1.59M	–	8669
2014 Q4	$1.59M	Buy	+84,216	New	+$1.52M	﹤0.01%	3182

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Citadel Advisors's IHI Position: Q1 2026 in Review

Citadel Advisors sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 49,552 shares — an estimated $2.91M sold.

Citadel Advisors first reported a position in IHI in Q4 2014 and held it in 31 quarters. The position peaked at $12.1M in Q1 2024. 512 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Citadel Advisors reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 49,552 iShares US Medical Devices ETF shares in Q1 2026, an estimated $2.91M.
Citadel Advisors first reported a position in iShares US Medical Devices ETF in Q4 2014 and held it in 31 quarters.
Citadel Advisors's iShares US Medical Devices ETF position peaked at $12.1M in Q1 2024.
512 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.